07:00 , May 14, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Carbonic anhydrase I (CAI); CAII; CAIX; CAXII

Ophthalmic disease INDICATION: Glaucoma In vitro and rabbit studies suggest carbonic anhydrase-inhibiting dendrimers could help treat glaucoma. Chemical synthesis and in vitro testing of poly(amidoamine) (PAMAM)-based dendrimers linked to multiple carbonic anhydrase-inhibiting benzenesulfonamide functional groups...
07:00 , Oct 31, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Lung cancer Carbonic anhydrase XII (CAXII) Cell culture and mouse studies identified an anti-CAXII mAb that could help treat cancer. In membrane fractions isolated from...